Mantle Cell Lymphoma: General Overview

Ian C. Langtree - Writer/Editor for Disabled World (DW)
Published: 2009/04/04 - Updated: 2023/01/30
Topic: Hodgkin's Lymphoma - Publications List

Page Content: Synopsis - Introduction - Main

Synopsis: Mantle Cell Lymphoma (MCL) is an aggressive (fast-growing) type of B-cell non-Hodgkin's lymphoma. MCL diagnosis is obtained by pathologic review of a lymph node biopsy or bone marrow specimen.

Introduction

Mantle Cell Lymphoma (MCL) is an aggressive (fast-growing) type of B-cell non-Hodgkin's lymphoma. Non-Hodgkin's lymphomas are related malignancies (cancers) that affect the lymphatic system (lymphomas).

The U.S. Social Security Administration (SSA) has included Mantle Cell Lymphoma (MCL) as a Compassionate Allowance to expedite a disability claim.

Main Item

It is marked by small to medium-sized cancer cells that may be in the lymph nodes, spleen, bone marrow, blood, and gastrointestinal system.

Alternate Names:

MCL is a B-cell lymphoma that develops from malignant B-lymphocytes within a region of the lymph node known as the "mantle zone."

MCL results from errors in the production of a lymphocyte or transformation of a lymphocyte into a malignant cell.

Abnormal, uncontrolled growth and multiplication (proliferation) of malignant lymphocytes may lead to

The specific symptoms and physical findings may vary from case to case, depending upon the extent and region(s) of involvement and other factors.

MCL primarily affects men over the age of 50 years.

Many affected individuals have widespread disease at diagnosis, with active regions often including multiple lymph nodes, the spleen, and, potentially, the bone marrow, the liver, and regions of the digestive (gastrointestinal) tract.

MCL diagnosis is obtained by pathologic review of a lymph node biopsy and bone marrow specimen. This usually includes flow cytometry testing and chromosomal analysis, which show CD5-positive cells, cyclin D1 protein over-expression, and translocation of chromosomes 11 and 14.

The treatment is chemotherapy, but the exact regimen of drugs may vary. Refractoriness to chemotherapy is usual, and unfortunately, high-dose stem cell transplants have not shown an overall survival benefit.

Classical MCL is characterized by an inferior prognosis. This cancer has the shortest average survival of all lymphoma types. Long-time survivors are rare; only a few patients with an overall survival over ten years have been reported.

Author Credentials: Ian was born and grew up in Australia. Since then, he has traveled and lived in numerous locations and currently resides in Montreal, Canada. Ian is the founder, a writer, and editor in chief for Disabled World. Ian believes in the Social Model of Disability, a belief developed by disabled people in the 1970s. The social model changes the focus away from people's impairments and towards removing barriers that disabled people face daily. To learn more about Ian's background, expertise, and achievements, .

Explore Similar Topics

: Lymphomas are the cancer of the lymphoid tissue so Hodgkins disease which is a type of lymphoma is also a cancer of this tissue.

: Mantle Cell Lymphoma (MCL) is an aggressive (fast-growing) type of B-cell non-Hodgkin's lymphoma.

Citing and References

Founded in 2004, Disabled World (DW) is a leading resource on disabilities, assistive technologies, and accessibility, supporting the disability community. Learn more on our About Us page.

Cite This Page: Disabled World. (2009, April 4 - Last revised: 2023, January 30). Mantle Cell Lymphoma: General Overview. Disabled World (DW). Retrieved April 30, 2025 from www.disabled-world.com/health/cancer/hodgkinsdisease/mantle-cell-lymphoma.php

Permalink: <a href="https://www.disabled-world.com/health/cancer/hodgkinsdisease/mantle-cell-lymphoma.php">Mantle Cell Lymphoma: General Overview</a>: Mantle Cell Lymphoma (MCL) is an aggressive (fast-growing) type of B-cell non-Hodgkin's lymphoma.

While we strive to provide accurate and up-to-date information, it's important to note that our content is for general informational purposes only. We always recommend consulting qualified healthcare professionals for personalized medical advice. Any 3rd party offering or advertising does not constitute an endorsement.